ONK Therapeutics
Latest round
- Series A
Last raised
- Jan 2022
Total raised
- $22M
Investors
- 3
About ONK Therapeutics
Founded in 2015 in Galway, Ireland, ONK Therapeutics Limited specializes in innovative NK cell therapies for cancer treatment. Co-founders Michael O'Dwyer and Tony Killarney have previously contributed to the biotechnology sector, with Chris Nowers currently serving as CEO.ONK Therapeutics specializes in next-generation, dual-targeted natural killer (NK) cell therapies, aimed at treating both solid and hematological cancers. The company's core product offerings revolve around optimally engineered off-the-shelf NK cell therapies that enhance cancer cell killing through advanced engineering strategies. These therapies are designed to improve tumor homing and persistence within the body while effectively addressing exhaustion within the tumor microenvironment. The end users of ONK Therapeutics' products primarily include oncology clinics, hospitals, and research institutions, which leverage these innovative therapies to provide advanced treatment options for patients battling various forms of cancer.50. The company’s revenue generation is largely attributed to partnerships and collaborations with academic institutions, clinical entities, and industry partners, focusing on the advancement and commercialization of its NK cell therapies. The company is also focused on developing its GMP manufacturing capability and optimizing its proprietary cell engineering platform. As part of its growth strategy, ONK Therapeutics aims to expand into new markets and geographic regions, although specific locations and timelines have not been detailed.
Who invested in ONK Therapeutics
3 investors across 1 round
See all investors in ONK Therapeutics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series A
Jan 6, 2022
Amount
$22M
Investors
Questions about ONK Therapeutics
Who invested in ONK Therapeutics?
ONK Therapeutics has 3 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has ONK Therapeutics raised?
ONK Therapeutics has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did ONK Therapeutics last raise money?
ONK Therapeutics's most recent round on record is a Series A, in Jan 2022.
What does ONK Therapeutics do?
Founded in 2015 in Galway, Ireland, ONK Therapeutics Limited specializes in innovative NK cell therapies for cancer treatment.
Where is ONK Therapeutics headquartered?
ONK Therapeutics is headquartered in Galway, Ireland.
Which VCs invest in companies like ONK Therapeutics?
Among active investors with capital left to deploy, Index Ventures, Forbion, European Investment Bank and Highland Europe back biotechnology companies at ONK Therapeutics's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like ONK Therapeutics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.